What is EBR Systems?
Founded in 2003, EBR Systems is a specialized medical device manufacturer dedicated to addressing the complexities of cardiac rhythm diseases. The company is best known for developing the WiSE Cardiac Resynchronization Therapy system, a pioneering leadless technology that offers a physiologic approach to cardiac pacing. By overcoming the anatomical and clinical limitations inherent in traditional resynchronization therapies, EBR Systems provides healthcare professionals in North America and Oceania with a sophisticated alternative for patient care. The firm operates at the intersection of high-stakes medical engineering and clinical application, serving both institutional healthcare providers and the broader cardiac management market.
How much funding has EBR Systems raised?
EBR Systems has raised a total of $200.9M across 10 funding rounds:
Unspecified
$15M
Series D
$5M
Private Equity
$18.7M
Private Equity
$20M
Private Equity
$50M
Other Financing Round
$30M
Debt
$1M
Unspecified (2009): $15M featuring Split Rock Partners and Delphi Ventures
Series D (2011): $5M, investors not publicly disclosed
Private Equity (2014): $18.7M with participation from The Foundry, ReShape Lifesciences, Delphi Ventures, and Split Rock Partners
Private Equity (2015): $20M led by Emergent Medical Partners, Delphi Ventures, Split Rock Partners, and SV Life Sciences
Private Equity (2017): $50M supported by M.H. Carnegie & Co, Emergent Medical Partners, Ascension Ventures, Brandon Capital Partners, and Split Rock Partners
Other Financing Round (2019): $30M featuring Ascension Ventures, M.H. Carnegie & Co., Brandon Capital Partners, Split Rock Partners, and Dr. Thomas Fogarty’s Emergent Medical Partners
Debt (2020): $1M backed by PPP
Key Investors in EBR Systems
Split Rock Partners
A venture capital firm that invests in leading software, Internet services, and healthcare companies across all stages of development, providing capital to companies from early revenue generation onward.
Delphi Ventures
A venture capital firm focused on early-stage investing in medical devices and biotechnology, with a track record of over 150 funded companies and numerous successful exits.
Ascension Ventures
A strategic healthcare venture firm that invests on behalf of leading community health systems to support private companies transforming the healthcare industry.
What's next for EBR Systems?
With the support of its latest strategic financing, EBR Systems is positioned to accelerate the commercial adoption of its leadless therapy platform. The company is expected to focus on expanding its clinical footprint across international markets, particularly within the Oceania region, while continuing to refine its device efficacy. As the firm transitions into a more mature enterprise lifecycle, the focus will likely shift toward scaling manufacturing capabilities and securing broader regulatory endorsements to solidify its status as a standard-of-care provider in the cardiac rhythm management sector.
See full EBR Systems company page
